Dr. Stephen D. Bell, MD

Dr. Bell practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Bell's NPI, 1215425749, was assigned on April 30, 2018. Dr. Bell graduated from American University of the Caribbean School of Medicine in 2017. Dr. Bell holds Florida license ME160519.

Dr. Bell's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Bell's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dr. Bell is also affiliated with St. Joseph Healthcare. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Bell to 3 more hospitals, 1 group practice or clinic, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bell practices, 7 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Bell's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Bell is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bell's licenses on file in 2 states: Florida and Maine.

Dmand AI lists arteritis, arthritis, joint arthropathy, joint pain, lower back pain, neck pain and spine problems, osteoporosis and rheumatoid arthritis among the conditions Dr. Bell treats.

CMS data shows 51,689 Medicare services from Dr. Bell across 15 procedure codes in 2024, for 521 Medicare patients. Medicare paid $703,673 for them. Every service was in an office.

CMS counts 521 Medicare patients who saw Dr. Bell in 2024. The largest group is 75 to 84, with 223 patients. 75% of them have arthritis, and 75% have high cholesterol. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bell's median patient age at 65, with 75% women.

In 2024, Dr. Bell wrote 410 Medicare Part D claims for 113 patients. 95% of them were for generic drugs. CMS names the drug for 327 of them, across 9 drugs with 11 or more claims each, at $26,530 in total drug cost. In 2023, CMS named 142 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Bell for performance year 2024, reported as part of a group. Dr. Bell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bell as offering telehealth.

Dmand AI links 8 papers to Dr. Bell, published from 2020 to 2025. 2020 was the busiest year, with 3. Dr. Bell has published most often in Cureus. Dr. Bell's most frequent co-authors are Natan Kraitman, MD, Qassem Khaled Abdelal, MD and Stephen Douglas Bell, DO.

CMS Open Payments shows 129 general payments to Dr. Bell from 15 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 96% of the total. Amgen Inc. paid the most, $783.

Dr. Bell graduated from American University of the Caribbean School of Medicine in 2017.

Dr. Bell is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.